Your browser doesn't support javascript.
loading
HER2 testing of multifocal invasive breast carcinoma: how many blocks are enough?
Bethune, Gillian C; Mullen, J Brendan; Chang, Martin C.
Afiliação
  • Bethune GC; Dept of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, 6-500, Toronto, ON M5G 1X5, Canada; e-mail: mchang2@mtsinai.on.ca.
Am J Clin Pathol ; 140(4): 588-92, 2013 Oct.
Article em En | MEDLINE | ID: mdl-24045558
OBJECTIVES: To determine the diagnostic yield of testing multiple blocks for HER2 in cases of multifocal breast carcinoma. METHODS: We identified 246 consecutive cases of multifocal invasive breast carcinoma in which HER2 was tested on more than 1 tumor focus. We performed an audit of all cases with respect to tumor size, grade, and histologic type. RESULTS: HER2 status was concordant between multiple foci in 230 (93.5%) of 246 cases, with the largest focus having the most positive HER2 result in 242 (98.4%) of 246 cases. We did not find a single case in which a smaller focus demonstrated a more positive HER2 status unless this focus was either higher grade or different histologically. CONCLUSIONS: Our findings support the evaluation of HER2 on the largest focus, with additional testing on smaller foci having a different histologic type or higher grade.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Manejo de Espécimes / Neoplasias da Mama / Carcinoma Ductal de Mama / Receptor ErbB-2 Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Manejo de Espécimes / Neoplasias da Mama / Carcinoma Ductal de Mama / Receptor ErbB-2 Idioma: En Ano de publicação: 2013 Tipo de documento: Article